Pharm-话题@MedSci

#Pharm#

730篇内容 | 2591人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787647, encodeId=28c51e876471f, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, objectType=article, longId=188697, objectId=625518869e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625518869e6a, replyNumber=0, likeNumber=61, createdTime=2020-02-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625518869e6a, moduleTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625518869e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787652, encodeId=79ce1e8765286, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：两种含丹参的中药处方抗肺纤维化功效对比, objectType=article, longId=189423, objectId=6edf189423f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6edf189423f2, replyNumber=0, likeNumber=66, createdTime=2021-01-10, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6edf189423f2, moduleTitle=Front Pharmacol：两种含丹参的中药处方抗肺纤维化功效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6edf189423f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787626, encodeId=eb4a1e8762649, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, objectType=article, longId=177301, objectId=41851e73015c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41851e73015c, replyNumber=0, likeNumber=55, createdTime=2019-09-16, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41851e73015c, moduleTitle=Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41851e73015c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787635, encodeId=71291e8763527, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ethnopharmacol：黑沙蒿提取物治疗过敏性鼻和鼻窦炎民族医学研究, objectType=article, longId=181749, objectId=06e5181e493f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e5181e493f, replyNumber=0, likeNumber=56, createdTime=2020-01-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e5181e493f, moduleTitle=J Ethnopharmacol：黑沙蒿提取物治疗过敏性鼻和鼻窦炎民族医学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e5181e493f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787623, encodeId=ae2d1e87623de, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, objectType=article, longId=176305, objectId=2c551e63051c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c551e63051c, replyNumber=0, likeNumber=79, createdTime=2019-12-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c551e63051c, moduleTitle=Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c551e63051c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787656, encodeId=ebe51e8765622, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Neuropharmacology：【实锤】父亲孕前饮酒增加后代大脑认知功能障碍，男性后代比女性后代更易受损害！, objectType=article, longId=191187, objectId=706319118e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=706319118e7a, replyNumber=0, likeNumber=83, createdTime=2020-10-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=706319118e7a, moduleTitle=Neuropharmacology：【实锤】父亲孕前饮酒增加后代大脑认知功能障碍，男性后代比女性后代更易受损害！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=706319118e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787642, encodeId=92891e87642cf, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, objectType=article, longId=187666, objectId=60c818e6662e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60c818e6662e, replyNumber=0, likeNumber=67, createdTime=2020-09-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60c818e6662e, moduleTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60c818e6662e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787619, encodeId=2b8a1e87619fa, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, objectType=article, longId=175404, objectId=17361e54044b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17361e54044b, replyNumber=0, likeNumber=53, createdTime=2020-01-22, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17361e54044b, moduleTitle=Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17361e54044b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787605, encodeId=d5ec1e87605f3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移, objectType=article, longId=164881, objectId=b51e164881ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b51e164881ee, replyNumber=0, likeNumber=48, createdTime=2019-11-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b51e164881ee, moduleTitle=Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b51e164881ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787651, encodeId=d1e51e876510c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险, objectType=article, longId=189388, objectId=d0ef189388b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0ef189388b4, replyNumber=0, likeNumber=79, createdTime=2020-04-20, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0ef189388b4, moduleTitle=Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0ef189388b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787629, encodeId=c49b1e87629c3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, objectType=article, longId=177350, objectId=81311e7350b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81311e7350b0, replyNumber=0, likeNumber=68, createdTime=2020-06-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81311e7350b0, moduleTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81311e7350b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787631, encodeId=77f51e876311f, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, objectType=article, longId=179627, objectId=a28c1e962734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a28c1e962734, replyNumber=0, likeNumber=62, createdTime=2020-01-03, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a28c1e962734, moduleTitle=Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a28c1e962734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787648, encodeId=a3c01e8764831, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Clin Pharmacol Drug Dev：HPβCD-双氯芬酸可用于轻度或中度肾功能不全或轻度肝功能不全的患者而无需调整剂量, objectType=article, longId=189081, objectId=505a189081fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505a189081fc, replyNumber=0, likeNumber=65, createdTime=2020-09-27, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505a189081fc, moduleTitle=Clin Pharmacol Drug Dev：HPβCD-双氯芬酸可用于轻度或中度肾功能不全或轻度肝功能不全的患者而无需调整剂量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=505a189081fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787617, encodeId=468f1e8761720, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Drug Dev Ind Pharm：木兰和小蜈蚣在治疗过敏性鼻炎中的药理学机制, objectType=article, longId=174688, objectId=bba71e4688dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba71e4688dc, replyNumber=0, likeNumber=73, createdTime=2020-06-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba71e4688dc, moduleTitle=Drug Dev Ind Pharm：木兰和小蜈蚣在治疗过敏性鼻炎中的药理学机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba71e4688dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787636, encodeId=b1601e87636dd, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染, objectType=article, longId=182393, objectId=3c1f1823939d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1f1823939d, replyNumber=0, likeNumber=59, createdTime=2019-11-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1f1823939d, moduleTitle=RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1f1823939d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787596, encodeId=d0121e8759647, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, objectType=article, longId=161805, objectId=b36616180596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b36616180596, replyNumber=0, likeNumber=59, createdTime=2019-05-24, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b36616180596, moduleTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b36616180596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787634, encodeId=17a31e876341c, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, objectType=article, longId=181662, objectId=2258181662f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2258181662f7, replyNumber=0, likeNumber=55, createdTime=2020-03-02, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2258181662f7, moduleTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2258181662f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787627, encodeId=ee0e1e8762794, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, objectType=article, longId=177308, objectId=61c21e7308ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c21e7308ae, replyNumber=0, likeNumber=52, createdTime=2020-02-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c21e7308ae, moduleTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c21e7308ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787620, encodeId=5a961e8762021, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=AbbVie收购Mavupharma，以抓住肿瘤免疫新靶点STING的机遇, objectType=article, longId=175615, objectId=cfd91e561593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd91e561593, replyNumber=0, likeNumber=59, createdTime=2019-09-12, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd91e561593, moduleTitle=AbbVie收购Mavupharma，以抓住肿瘤免疫新靶点STING的机遇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd91e561593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787639, encodeId=70521e8763921, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, objectType=article, longId=186097, objectId=245d18609efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245d18609efa, replyNumber=0, likeNumber=63, createdTime=2020-02-22, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245d18609efa, moduleTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245d18609efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染

2020-02-26

柳叶一刀 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：两种含丹参的中药处方抗肺纤维化功效对比

2021-01-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci：研究揭示LncRNA-H19通过靶向miR-29a-3p抑制急性髓细胞白血病细胞的凋亡

2019-09-16

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Ethnopharmacol：黑沙蒿提取物治疗过敏性鼻和鼻窦炎民族医学研究

2020-01-27

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Immunopharmacol Immunotoxicol：Sulglycotide通过阻断NF-κB信号传导途径改善巨噬细胞中的炎症

2019-12-01

柳叶一刀 (审核中...)

前往app查看评论内容

#Pharm#

Neuropharmacology：【实锤】父亲孕前饮酒增加后代大脑认知功能障碍，男性后代比女性后代更易受损害！

2020-10-30

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎

2020-09-27

docwu2019 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci:妊娠可影响牙周病的发展

2020-01-22

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移

2019-11-07

柳叶一刀 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险

2020-04-20

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死

2020-06-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Lundbeck以近20亿美元收购Alder BioPharmaceuticals，获得CGRP抑制剂eptinezumab的权利

2020-01-03

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Clin Pharmacol Drug Dev：HPβCD-双氯芬酸可用于轻度或中度肾功能不全或轻度肝功能不全的患者而无需调整剂量

2020-09-27

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Drug Dev Ind Pharm：木兰和小蜈蚣在治疗过敏性鼻炎中的药理学机制

2020-06-04

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染

2019-11-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号

2019-05-24

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险

2020-03-02

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生

2020-02-22

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

AbbVie收购Mavupharma，以抓住肿瘤免疫新靶点STING的机遇

2019-09-12

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布

2020-02-22

科室
- - 订阅+
  - 更多科室
工具
服务